Oseltamivir (Tamiflu) in the treatment of patients infected with COVID-19. An overview of its use as a therapy
DOI:
https://doi.org/10.35319/conr.20224227Abstract
In late December 2019, a new pneumonia of unknown origin was detected in patients linked to a wholesale seafood and wet animal market in Wuhan, Hubei Province, China. After analyzing respiratory epithelial cell samples from one patient, a beta coronavirus closely related to the one that causes severe acute respiratory syndrome (SARS-CoV) was detected. This new coronavirus was provisionally described as novel coronavirus (2019-nCoV); however, on February 11, 2020, the World Health Organization named the disease caused by 2019-nCoV “Coronavirus Disease 2019” (COVID-19).
Downloads
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Neumonía in China, 2019. N Engl J Med 2020;382(8):727-33. DOI: https://doi.org/10.1056/NEJMoa2001017
World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 1 [Internet]. Gineva: Institutional Repository for Information Sharing; 2020 [cited 2 October 2022]. 5 p. Retrieved from: https://apps.who.int/iris/handle/10665/330760
Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int J Infect Dis 2020;98:180-6. DOI: https://doi.org/10.1016/j.ijid.2020.06.052
Chen C, Zhu C, Yan D, Liu H, Li D, Zhou Y, et al. The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis. Int J Infect Dis 2021;104:458-64. DOI: https://doi.org/10.1016/j.ijid.2021.01.017
Enfermedad por coronavirus (COVID-19): ¿Cómo se transmite? [Internet]. Organización Mundial de la Salud. 2021 [citado 5 de noviembre 2022]. Recuperado a partir de: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted
Número de vacunas contra el coronavirus a nivel mundial a fecha de 29 de marzo de 2021, por tipo de vacuna y fase de desarrollo [Internet]. Statista. 2021 [citado 5 de noviembre de 2022]. Recuperado a partir de: https://es.statista.com/estadisticas/1135710/covid-19-numero-de-vacunas-candidatas-en-el-mundo-por-fase-y-tipo/
Yousefi H, Mashouri L, Okpechi SC, Alahari N, Alahari SK. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Biochem Pharmacol 2021; 183:114296. DOI: https://doi.org/10.1016/j.bcp.2020.114296
Aliyu B, Raji YE, Chee HY, Wong MY, Sekawi ZB. Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19). PLoS One 2022;17 (12):e0277206. DOI: https://doi.org/10.1371/journal.pone.0277206
Zhang XW, Yap YL. The 3D structure analysis of SARS-CoV S1 protein reveals a link to influenza virus neuraminidase and implications for drug and antibody discovery. Theochem 2004;681(1):137-41. DOI: https://doi.org/10.1016/j.theochem.2004.04.065
Wang J, Yang W, Chen P, Guo J, Liu R, Wen P, et al. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis. PLoS One 2021;16(4):e0249481. DOI: https://doi.org/10.1371/journal.pone.0249481
Tan Q, Duan L, Ma Y, Wu F, Huang Q, Mao K, et al. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Bioorg Chem 2020;104:104257. DOI: https://doi.org/10.1016/j.bioorg.2020.104257
Matsunaga N, Oki Y, Prigollini A. A case of QT-interval prolongation precipitated by azithromycin. N Z Med J 2003;116(1185):U666.
Samarendra P, Kumari S, Evans SJ, Sacchi TJ, Navarro V. QT prolongation associated with azithromy-cin/amiodarone combination. Pacing Clin Electrophysiol 2001;24(10):1572-4. DOI: https://doi.org/10.1046/j.1460-9592.2001.01572.x
Russo V, Puzio G, Siniscalchi N. Azithromycin-induced QT prolongation in elderly patient. Acta Biomed 2006; 77(1):30-2.
Saleh M, Gabriels J, Chang D, Soo Kim B, Mansoor A, Mahmood E, et al. Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol 2020;13(6):e008662. DOI: https://doi.org/10.1161/CIRCEP.120.008662
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Current Opinion Nursing & Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
